Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, et al. Alternating 17beta-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clin Cancer Res 2023 Jun 1:OF1-OF7. doi: 10.1158/1078-0432.CCR-23-0112.
PMID: 37260292